Stensen's duct dilation: case series of minimally invasive treatment

Publication date: Available online 7 February 2019

Source: Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology

Author(s): Le Roux Marc-Kevin, Graillon Nicolas, Hadj-Saïd Mehdi, Scemama Ugo, Lutz Jean-Christophe, Chossegros Cyrille

Abstract

Stensen's duct dilation is a rare condition defined by a global or partial idiopathic dilation of the Stensen's duct. Affected patients usually show either aesthetic features, such as a tubular-shaped swelling in the cheek, or with mildly painful inflammatory episodes. Three women between the ages of 61 and 67 years were diagnosed with Stensen's duct dilatation after sialoMRI. They were treated with botulinum toxin A (BTX-A). Our preliminary results suggest that Botulinum Toxin A was efficient as a suspensive treatment. BTX-A should prevail as a first-line treatment of the early silent symptoms of Stensen's duct dilation like swelling and aesthetic discomfort. The use of BTX-A avoids more serious procedures and further complications.

http://bit.ly/2Se8cRc